Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Annales D'Endocrinologie
|
October 20, 2011
[Pituitary disease: which treatment in the future?]
C Briet, P Chanson
Neuro-Chirurgie
|
September 9, 2017
Lesson to be remembered from a skull base tumor
C Briet, F Bernard, P Rodien
International Journal of Peptide and Protein Research
|
September 1, 1985
Synthesis of Z-CCK-27-32-NH2, Z-Tyr(SO-3)-Met-Gly-Trp-Met-Asp-NH2, a cholecystokinin receptor antagonist and an inhibitor of gastrin-induced acid secretion
C Briet, A Aumelas, J Martinez
European Journal of Pharmacology
|
March 4, 1986
Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice
P Worms, J Martinez, C Briet, et al.
Diabetes, Obesity & Metabolism
|
September 6, 2013
The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives
S Luce, C Briet, C Bécourt, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 13, 2018
TRα Mutations in Human
C Briet, Natacha Bouhours-Nouet, F Illouz, et al.
Diabetes & Metabolism
|
January 15, 2014
Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation
J D Lalau, M L Azzoug, F Kajbaf, et al.
The Journal of Biological Chemistry
|
June 10, 1983
Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists
M Spanarkel, J Martinez, C Briet, et al.
Annales D'Endocrinologie
|
February 24, 2007
The use of intravenous catheterisation with a rest period is useful for determination of plasma cortisol levels but not plasma prolactin levels
C Briet, M Saraval, S Loric, et al.
Clinical Genetics
|
May 12, 2018
New case of bilateral pheochromocytomas involving the homozygous TMEM127 mutation
S Laboureau, A Guichet, T Duriez, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Annales D'Endocrinologie
|
October 20, 2011
[Pituitary disease: which treatment in the future?]
C Briet, P Chanson
Neuro-Chirurgie
|
September 9, 2017
Lesson to be remembered from a skull base tumor
C Briet, F Bernard, P Rodien
International Journal of Peptide and Protein Research
|
September 1, 1985
Synthesis of Z-CCK-27-32-NH2, Z-Tyr(SO-3)-Met-Gly-Trp-Met-Asp-NH2, a cholecystokinin receptor antagonist and an inhibitor of gastrin-induced acid secretion
C Briet, A Aumelas, J Martinez
European Journal of Pharmacology
|
March 4, 1986
Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice
P Worms, J Martinez, C Briet, et al.
Diabetes, Obesity & Metabolism
|
September 6, 2013
The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives
S Luce, C Briet, C Bécourt, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 13, 2018
TRα Mutations in Human
C Briet, Natacha Bouhours-Nouet, F Illouz, et al.
Diabetes & Metabolism
|
January 15, 2014
Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation
J D Lalau, M L Azzoug, F Kajbaf, et al.
The Journal of Biological Chemistry
|
June 10, 1983
Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists
M Spanarkel, J Martinez, C Briet, et al.
Annales D'Endocrinologie
|
February 24, 2007
The use of intravenous catheterisation with a rest period is useful for determination of plasma cortisol levels but not plasma prolactin levels
C Briet, M Saraval, S Loric, et al.
Clinical Genetics
|
May 12, 2018
New case of bilateral pheochromocytomas involving the homozygous TMEM127 mutation
S Laboureau, A Guichet, T Duriez, et al.
Page
of 2